top of page
Medex EU Authorised Representative logo

EU Authorized Representative for Intraocular Lens Manufacturers: Rule 8, Implant Card and the Mandate

An intraocular lens is an implantable device under Regulation (EU) 2017/745, and Rule 8 of Annex VIII places it in class IIb. Because it is a class IIb implant, the notified body assesses the technical documentation of every lens model, and the implant card, the summary of safety and clinical performance and 15-year document retention all apply. A lens manufacturer established outside the Union must designate a sole authorized representative under Article 11, and one mandate covers the EU and Türkiye.

An intraocular lens is an implantable device

Article 2(5) defines an implantable device as one intended to be totally introduced into the body, or "to replace an epithelial surface or the surface of the eye," (MDR Article 2(5)), by clinical intervention and intended to remain after the procedure. A lens placed in the capsular bag during cataract surgery meets the first limb outright, and MDCG 2021-24 names ophthalmic implants among the groups Rule 8 is written for:

"These are mostly implants in the orthopaedic, dental, ophthalmic and cardiovascular fields as well as soft tissue implants such as implants used in plastic surgery." (MDCG 2021-24, Rule 8, general explanation)

Rule 8 places intraocular lenses in class IIb

"All implantable devices and long-term surgically invasive devices are classified as class IIb unless they:" (MDR Annex VIII, Rule 8)

  • "are intended to be used in direct contact with the heart, the central circulatory system or the central nervous system, in which case they are classified as class III;"
  • "have a biological effect or are wholly or mainly absorbed, in which case they are classified as class III;"

MDCG 2021-24 lists intra-ocular lenses as a class IIb example under the general rule. The eye is not part of the central circulatory or nervous system as Annex VIII defines them, and a conventional acrylic or silicone lens has no biological effect and is not absorbed. Monofocal, multifocal, toric and extended depth of focus lenses are all class IIb; the optical design changes the clinical evaluation, not the class. A phakic lens implanted in front of the natural lens is in the same position. Two branches would move a lens up: a surface coating claimed to be bioactive falls under the biological effect indent, where MDCG 2021-24 lists implantable devices claimed to be bioactive through surface coatings as class III, and a lens incorporating a medicinal substance with an ancillary action falls under Rule 14.

Class IIb implantable: every lens model is assessed

"Manufacturers of class IIb devices, other than custom-made or investigational devices, shall be subject to a conformity assessment as specified in Chapters I and III of Annex IX, and including an assessment of the technical documentation as specified in Section 4 of that Annex of at least one representative device per generic device group." (MDR Article 52(4))

"However, for class IIb implantable devices, except sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors, the assessment of the technical documentation as specified in Section 4 of Annex IX shall apply for every device." (MDR Article 52(4), second subparagraph)

Intraocular lenses are not on that list, so the notified body assesses the technical documentation of every lens model rather than sampling one per generic device group. The clinical evaluation covers visual outcomes, posterior capsule opacification, dysphotopsia and, for toric designs, rotational stability.

Implant card, SSCP and 15-year retention

"In addition, the manufacturer shall provide the information referred to in point (a) of the first subparagraph on an implant card delivered with the device." (MDR Article 18(1))

Intraocular lenses are not among the implants exempted by Article 18(3), and cataract surgery is one of the most frequent implant procedures, so the implant card and patient information must exist in the languages determined by every Member State in which the lens is sold. Article 32 applies as well:

"For implantable devices and for class III devices, other than custom-made or investigational devices, the manufacturer shall draw up a summary of safety and clinical performance." (MDR Article 32(1))

Article 10(8) sets 15 years as the retention period for the technical documentation of implantable devices, and the authorized representative mirrors it under Article 11(3)(b).

Injectors, viscoelastics and capsular tension rings

Each product in a cataract kit is classified in its own right under Section 3.2. A single-use injector or cartridge enters the eye through the corneal incision for seconds, so it is a surgically invasive device for transient use:

"All surgically invasive devices intended for transient use are classified as class IIa unless they:" (MDR Annex VIII, Rule 6)

  • "have a biological effect or are wholly or mainly absorbed in which case they are classified as class IIb; or"

No indent applies to a plain injector, so it is class IIa. MDCG 2021-24 lists viscoelastic solution for ophthalmic surgery as class IIb under the biological effect indent of Rule 6, and notes under Rule 8 that visco-elastic surgical devices intended specifically for anterior segment surgery are implants because a significant amount of substance remains at the surgical site. A capsular tension ring stays in the eye and is a class IIb implant under Rule 8.

Classification table for an intraocular lens range

Product variantClassRuleNotified body
Monofocal, toric, multifocal or extended depth of focus posterior chamber lensIIbRule 8, general ruleYes; every model assessed, implant card, SSCP
Phakic intraocular lensIIbRule 8, general ruleYes; every model assessed, implant card, SSCP
Lens claimed bioactive through a surface coatingIIIRule 8, biological effect indentYes; Article 54 consultation
Lens incorporating a medicinal substance with ancillary actionIIIRule 14Yes; medicines authority consultation
Capsular tension ringIIbRule 8, general ruleYes; implant obligations
Single-use lens injector or cartridge, supplied separatelyIIaRule 6Yes
Preloaded lens in injector, placed on the market as one deviceIIbRule 8 with Section 3.5Yes
Ophthalmic viscoelastic deviceIIbRule 6, biological effect indent; Rule 8 where it remains at the siteYes

What the authorized representative mandate covers for intraocular lenses

The appointment turns on where the manufacturer is established, not on the class of the device:

"Where the manufacturer of a device is not established in a Member State, the device may only be placed on the Union market if the manufacturer designates a sole authorised representative." (MDR Article 11(1))

Article 11(3) fixes the minimum tasks:

"The mandate shall require, and the manufacturer shall enable, the authorised representative to perform at least the following tasks in relation to the devices that it covers:" (MDR Article 11(3))

  • "verify that the EU declaration of conformity and technical documentation have been drawn up and, where applicable, that an appropriate conformity assessment procedure has been carried out by the manufacturer;"
  • "comply with the registration obligations laid down in Article 31 and verify that the manufacturer has complied with the registration obligations laid down in Articles 27 and 29;"

Lens ranges run to thousands of dioptre and cylinder combinations under a handful of Basic UDI-DIs. The representative checks that the UDI structure and the EUDAMED device records match the certificate scope, and that complaints from surgeons about explantation or exchange reach the manufacturer immediately.

One mandate for the European Union and Türkiye

Medex Kurumsal Danışmanlık acts as EU authorized representative under EUDAMED SRN TR-AR-000057550, with offices in Ankara and İstanbul. A manufacturer of intraocular lenses established outside the EU and Türkiye does not need two representatives:

"manufacturers established outside the territory of the EU or Turkey only need to designate one authorised representative, either in the EU or in Turkey, in order to place medical devices on the market in the EU or in Turkey." (European Commission, Notice to Stakeholders, EU-Turkey Customs Union Agreement in the field of medical devices, March 2022, section I.2)

"The ’Union market’ refers to the territories of the European Union Member States, and due to the European Economic Area (EEA) is extended to Norway, Lichtenstein and Iceland, and via the Customs Union Agreement to Turkey." (MDCG 2022-16, footnote 1)

Our mandate covers the EU Member States and Türkiye; we are not a Swiss representative or UK Responsible Person, not a notified body, and we do not find importers or distributors. The published bands on our pricing page are €1,200 to 1,600 per year for class IIb, with a €0 setup fee and rates fixed for three years from signature. Registration of the same intraocular lenses in ÜTS (Ürün Takip Sistemi), Türkiye's product tracking system, is a separate service: ÜTS registration of intraocular lenses in Türkiye (Turkish).

The symbol that identifies the representative on your label is explained in our guide to the EC REP meaning. If some devices are still placed on the market under the former directives, see the authorized representative for legacy devices.

Related device categories and country pages

Other ophthalmic groups: contact lenses and spectacle frames and ophthalmic optics. Implant obligations are covered in more depth on the orthopedic implants page. All groups are listed on the medical device categories page, and the manufacturer country pages start from the EU authorized representative by country list.

Frequently asked questions

Which class is a monofocal intraocular lens?

Class IIb. It is an implantable device and Rule 8 places implantable devices in class IIb unless an indent applies. MDCG 2021-24 lists intra-ocular lenses as a class IIb example. Toric, multifocal and extended depth of focus designs are in the same class.

Is every lens model assessed by the notified body?

Yes. Article 52(4) requires the assessment of the technical documentation for every class IIb implantable device except sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors. Intraocular lenses are not on that list.

Does an intraocular lens need an implant card?

Yes. Article 18 applies to every implantable device and the exemption list in Article 18(3) does not include intraocular lenses. The card and the patient information must be in the languages determined by each Member State.

Is the lens injector classified with the lens?

Supplied separately, no. Under Annex VIII, Section 3.2 it is classified in its own right, and as a surgically invasive device for transient use it is class IIa under Rule 6. A preloaded lens placed on the market as one device with its injector takes the higher class under Section 3.5.

Does one mandate cover the European Union and Türkiye?

Yes. The European Commission's Notice of March 2022 states that a manufacturer established outside the EU and Türkiye only needs to designate one authorized representative, either in the EU or in Türkiye. Medex is established in Türkiye under EUDAMED SRN TR-AR-000057550.

Sources and further reading

Regulation (EU) 2017/745 on medical devices (MDR), Articles 2, 10, 11, 18, 32, 52 and 54, Annex VIII - eur-lex.europa.eu

MDCG 2021-24, Guidance on classification of medical devices (October 2021) - health.ec.europa.eu

MDCG 2022-16, Guidance on authorised representatives (Regulation (EU) 2017/745 and Regulation (EU) 2017/746) - health.ec.europa.eu

European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices (March 2022) - health.ec.europa.eu

Get a fixed-price EU REP quote for your intraocular lens range (reply within 1 business day).

Request a proposal  ·  View pricing  ·  Our EU REP service

bottom of page